Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Launch76358 grounded factsnewest September 3, 2026, 8:05 AM ETRSS · JSON
Showing 6701–6750 of 18647
Appointed
(interim)
Justin Pugh
Acting Chief Financial Officer
Proterra Inc
Effective
2024-02-01
Filed
February 1, 2024, 6:59 PM ET
Effective as of February 1, 2024, the Restructuring Committee of the Boards of Directors of the Debtors (which has been vested with the full power and authority of the Boards of Directors of the Debtors with respect to certain activities related to the Debtors’ Chapter 11 Cases) approved that Mr. Pugh, in his capacity as the Debtors’ Chief Transformation Officer, shall assume all of the responsibilities, and the authority to act on behalf of the Debtors, of the Debtors’ acting Chief Financial Officer until a permanent Chief Financial Officer is appointed
Departed
David S. Black
Chief Financial Officer
Proterra Inc
Effective
2024-02-01
Successor
Justin Pugh
Filed
February 1, 2024, 6:59 PM ET
David S. Black resigned as Chief Financial Officer of the Company.
On January 29, 2024, the Company entered into an employment agreement (the “ Employment Agreement ”) with Justin C. Jacobs, age 49, pursuant to which Mr. Jacobs was appointed Chief Executive Officer of the Company, effective February 12, 2024
On January 31, 2024, the Board of Directors (the “Board”) of Immunome, Inc. (the “Company”) promoted Max Rosett, the Company’s Senior Vice President, Operations and Interim Chief Financial Officer to Executive Vice President, Operations and Interim Chief Financial Officer (the “Promotion”).
On January 30, 2024, Trevena, Inc. (the “Company”) promoted Barry Shin to the position of Executive Vice President, Chief Operating Officer & Chief Financial Officer, effective as of February 1, 2024.
On February 1, 2024, the Board of Directors (the “Board”) of DXC Technology Company (the “Company” or “DXC”) appointed Raul J. Fernandez as President and Chief Executive Officer of the Company, effective February 1, 2024.
Appointed
Kara Cannon
Chief Executive Officer
ENZO BIOCHEM INC
Effective
2024-01-31
Filed
February 1, 2024, 6:59 PM ET
On January 31, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Kara Cannon to serve as the Chief Executive Officer of the Company and Patricia Eckert, CPA, to serve as the Chief Financial Officer of the Company, in each case, until her successor is duly elected and qualified.
Appointed
Patricia Eckert
Chief Financial Officer
ENZO BIOCHEM INC
Effective
2024-01-31
Filed
February 1, 2024, 6:59 PM ET
On January 31, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Kara Cannon to serve as the Chief Executive Officer of the Company and Patricia Eckert, CPA, to serve as the Chief Financial Officer of the Company, in each case, until her successor is duly elected and qualified.
Effective upon the commencement of Mr. Doherty's employment, Daniel O'Connell's position would be updated to Chief Executive Officer.
Departed
(interim)
Michael Ramke
Interim Chief Financial Officer
ADDVANTAGE TECHNOLOGIES GROUP INC
Effective
2024-01-31
Filed
February 1, 2024, 6:59 PM ET
Joseph E. Hart, the Company’s Chief Executive Officer and President; and Michael Ramke, the Company’s Interim Chief Financial Officer, resigned as executive officers of the Company.
Departed
Joseph E. Hart
Chief Executive Officer and President
ADDVANTAGE TECHNOLOGIES GROUP INC
Effective
2024-01-31
Filed
February 1, 2024, 6:59 PM ET
Joseph E. Hart, the Company’s Chief Executive Officer and President; and Michael Ramke, the Company’s Interim Chief Financial Officer, resigned as executive officers of the Company.
appointed Andrew J. ("A.J.") Eaker as the Company's Executive Vice President, Chief Financial Officer (principal financial officer and principal accounting officer), and Treasurer, effective immediately.
On January 31, 2024, CVRx, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed Kevin Hykes as President and Chief Executive Officer (“CEO”), effective February 12, 2024.
appointed Christopher Fenimore, currently the Company’s Senior Vice President, Controller, as Senior Vice President, Finance and Chief Financial Officer
The Company appointed Mark Mauldin, the Company’s Chief Accounting Officer, to serve as the Company’s interim Chief Financial Officer beginning on February 2, 2024.
On January 26, 2024, the Board appointed Mr. Henrichs to serve as the CFO (the “CFO Appointment”). Mr. Henrichs’s employment will begin on February 5, 2024
Effective January 29, 2024, Mr. Walter Tabaschek (“ Tabaschek ”) resigned as KeyStar Corp’s., a Nevada corporation (the “ Company ”) Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer.
On January 29, 2024, Mobivity Holdings Corp. (the “Company”) announced that Skye Fossey-Tomaske was appointed to serve as the Interim Chief Financial Officer of the Company, effective as of January 29, 2024.
On January 29, 2024, Will Sanchez and the Board of Directors (the “Board”) of Mobivity Holdings Corp. (the “Company”) have mutually agreed that Mr. Sanchez will end his employment as Chief Financial Officer of the Company.
On January 31, 2024, Rhinebeck Bancorp, Inc. (the “Company”), the holding company of Rhinebeck Bank, announced the retirement of Michael J. McDermott, Chief Financial Officer of the Company.
Departed
Jeff Hackman
President, Chief Executive Officer and Director
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Successor
Michael Campbell
Filed
January 30, 2024, 6:59 PM ET
the Company terminated the employment of Jeff Hackman, President, Chief Executive Officer and Director, Michael Campbell, Executive Vice President and Chief Financial Officer, and Robert Mahoney, Chief Scientific Officer effective January 31, 2024.
Departed
Michael Campbell
Executive Vice President and Chief Financial Officer
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Filed
January 30, 2024, 6:59 PM ET
the Company terminated the employment of Jeff Hackman, President, Chief Executive Officer and Director, Michael Campbell, Executive Vice President and Chief Financial Officer, and Robert Mahoney, Chief Scientific Officer effective January 31, 2024.
Appointed
Michael Campbell
Chief Executive Officer and Chief Financial Officer
Comera Life Sciences Holdings, Inc.
Effective
2024-01-31
Filed
January 30, 2024, 6:59 PM ET
the Company engaged Mr. Campbell as a consultant and appointed him to serve as the Company’s Chief Executive Officer and Chief Financial Officer effective immediately following the termination of his employment on January 31, 2024.
Departed
Samat Sultanalievich Nurmakhanov
Director, President, and CEO
China Solar & Clean Energy Solutions, Inc.
Effective
2023-12-28
Successor
Shelli Fields
Filed
January 30, 2024, 6:59 PM ET
On December 28, 2023, Samat Sultanalievich Nurmakhanov resigned from all positions, including Director, President, and CEO , of China Solar and Clean Energy Solutions, Inc. (the “Company”).
Appointed
Michael A. Marks
Executive Vice President and Chief Financial Officer
On January 30, 2024, the Company announced that Michael A. Marks, age 54, will succeed Mr. Rutherford as Executive Vice President and Chief Financial Officer, effective May 1, 2024.
Departed
William B. Rutherford
Executive Vice President and Chief Financial Officer
On January 24, 2024, William B. Rutherford notified the Company of his intent to retire from his position as Executive Vice President and Chief Financial Officer, effective May 1, 2024.
On January 29, 2024, the Board of Directors (the “Board”) of the Company appointed Todd Suko to serve as Interim Chief Financial Officer, effective February 1, 2024,
The RealReal, Inc. (the “Company”) previously announced the departure of Robert Julian, Chief Financial Officer, effective January 31, 2024.
Appointed
George England
Chief Executive Officer
Global Vision Holdings, Inc.
Effective
2024-01-30
Filed
January 30, 2024, 6:59 PM ET
Effective January 30, 2024, I Glen W. Carnes would like to inform you that I am resigning from my position as CEO and making way for “ George England” to take over as the new CEO of Global Vision Holdings, Inc.
Departed
Glen W. Carnes
Chief Executive Officer
Global Vision Holdings, Inc.
Effective
2024-01-30
Successor
George England
Filed
January 30, 2024, 6:59 PM ET
Effective January 30, 2024, I Glen W. Carnes would like to inform you that I am resigning from my position as CEO and making way for “ George England” to take over as the new CEO of Global Vision Holdings, Inc.
former Interim Chief Financial Officer, Fatima Dhalla, has resigned as the Interim Chief Financial Officer of the Company , effective January 19, 2024.
On January 24, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Ms. Stacy McLaughlin to serve as Chief Financial Officer of the Company, effective as of the same date.
Appointed
Victoria Eatwell
Chief Financial Officer
2seventy bio, Inc.
Filed
January 30, 2024, 6:59 PM ET
On January 29, 2024, the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.